Control of telomerase action at human telomeres

Nature Structural and Molecular Biology

Volumn 22, Issue 11, 2015, Pages 848-852

  Hockemeyer, Dirk ^a,b   Collins, Kathleen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Berkeley   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOLOENZYME; SHELTERIN; TELOMERASE; UNCLASSIFIED DRUG; DNA; PROTEIN BINDING; SHELTERIN, HUMAN; TELOMERE BINDING PROTEIN;

ENZYME REGULATION; HOMEOSTASIS; HUMAN; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TELOMERE; BIOLOGICAL MODEL; METABOLISM; TELOMERE HOMEOSTASIS;

DNA; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; TELOMERASE; TELOMERE HOMEOSTASIS; TELOMERE-BINDING PROTEINS;

EID: 84947915249     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.3083     Document Type: Review

References (83)

1. Doksani, Y. & de Lange, T. The role of double-strand break repair pathways at functional and dysfunctional telomeres. Cold Spring Harb. Perspect. Biol. 6, a016576 (2014).
2. Wang, F. et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506-510 (2007).
3. Xin, H. et al. TPP1 is a homologue of ciliate TEBP and interacts with POT1 to recruit telomerase. Nature 445, 559-562 (2007).
4. Abreu, E. et al. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol. Cell. Biol. 30, 2971-2982 (2010).
5. Aubert, G. Telomere dynamics and aging. Prog. Mol. Biol. Transl. Sci. 125, 89-111 (2014).
6. Holohan, B., Wright, W. E. & Shay, J. W. Telomeropathies: An emerging spectrum disorder. J. Cell Biol. 205, 289-299 (2014).
7. Shay, J. W. & Wright, W. E. Role of telomeres and telomerase in cancer. Semin. Cancer Biol. 21, 349-353 (2011).
8. Stewart, J. A., Chaiken, M. F., Wang, F. & Price, C. M. Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat. Res. 730, 12-19 (2012).
9. Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 503-514 (1999).
10. Doksani, Y., Wu, J. Y., de Lange, T. & Zhuang, X. Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. Cell 155, 345-356 (2013).
11. Kabir, S., Hockemeyer, D. & de Lange, T. TALEN gene knockouts reveal no requirement for the conserved human shelterin protein Rap1 in telomere protection and length regulation. Cell Rep. 9, 1273-1280 (2014).
12. Ye, J. Z. et al. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J. Biol. Chem. 279, 47264-47271 (2004).
13. Mattern, K. A. et al. Dynamics of protein binding to telomeres in living cells: implications for telomere structure and function. Mol. Cell. Biol. 24, 5587-5594 (2004).
14. Takai, K. K., Hooper, S., Blackwood, S., Gandhi, R. & de Lange, T. In vivo stoichiometry of shelterin components. J. Biol. Chem. 285, 1457-1467 (2010).
15. Egan, E. D. & Collins, K. Biogenesis of telomerase ribonucleoproteins. RNA 18, 1747-1759 (2012).
16. Podlevsky, J. D. & Chen, J. J. It all comes together at the ends: Telomerase structure, function, and biogenesis. Mutat. Res. 730, 3-11 (2012).
17. Schmidt, J. C. & Cech, T. R. Human telomerase: biogenesis, trafficking, recruitment, and activation. Genes Dev. 29, 1095-1105 (2015).
18. Collins, K. Physiological assembly and activity of human telomerase complexes. Mech. Ageing Dev. 129, 91-98 (2008).
19. Nandakumar, J. & Cech, T. R. Finding the end: recruitment of telomerase to telomeres. Nat. Rev. Mol. Cell Biol. 14, 69-82 (2013).
20. Darzacq, X. et al. Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells. J. Cell Biol. 173, 207-218 (2006).
21. Egan, E. D. & Collins, K. An enhanced H/ACA RNP assembly mechanism for human telomerase RNA. Mol. Cell. Biol. 32, 2428-2439 (2012).
22. Kiss, T., Fayet-Lebaron, E. & Jády, B. E. Box H/ACA small ribonucleoproteins. Mol. Cell 37, 597-606 (2010).
23. Richard, P. et al. A common sequence motif determines the Cajal body-specific localization of box H/ACA scaRNAs. EMBO J. 22, 4283-4293 (2003).
24. Tycowski, K. T., Shu, M. D., Kukoyi, A. & Steitz, J. A. A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. Mol. Cell 34, 47-57 (2009).
25. Venteicher, A. S. et al. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323, 644-648 (2009).
26. Weinrich, S. L. et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17, 498-502 (1997).
27. Mitchell, J. R. & Collins, K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase in vivo and in vitro. Mol. Cell 6, 361-371 (2000).
28. Chen, J. L., Opperman, K. K. & Greider, C. W. A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res. 30, 592-597 (2002).
29. Zhang, Q., Kim, N. K. & Feigon, J. Architecture of human telomerase RNA. Proc. Natl. Acad. Sci. USA 108, 20325-20332 (2011).
30. Tomlinson, R. L., Ziegler, T. D., Supakorndej, T., Terns, R. M. & Terns, M. P. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 17, 955-965 (2006).
31. Lee, J. H. et al. Catalytically active telomerase holoenzyme is assembled in the dense fibrillar component of the nucleolus during S phase. Histochem. Cell Biol. 141, 137-152 (2014).
32. Hug, N. & Lingner, J. Telomere length homeostasis. Chromosoma 115, 413-425 (2006).
33. Jády, B. E., Richard, P., Bertrand, E. & Kiss, T. Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol. Biol. Cell 17, 944-954 (2006).
34. Blackburn, E. H., Greider, C. W. & Szostak, J. W. Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 12, 1133-1138 (2006).
35. Britt-Compton, B. et al. Structural stability and chromosome-specific telomere length is governed by cis-acting determinants in humans. Hum. Mol. Genet. 15, 725-733 (2006).
36. Cristofari, G. & Lingner, J. Telomere length homeostasis requires that telomerase levels are limiting. EMBO J. 25, 565-574 (2006).
37. Greider, C. W. Telomerase RNA levels limit the telomere length equilibrium. Cold Spring Harb. Symp. Quant. Biol. 71, 225-229 (2006).
38. Armanios, M. & Blackburn, E. H. The telomere syndromes. Nat. Rev. Genet. 13, 693-704 (2012).
39. Chiba, K. et al. Cancer-associated TERT promoter mutations abrogate telomerase silencing. eLife 4, e07918 (2015).
40. Fu, D. & Collins, K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol. Cell 28, 773-785 (2007).
41. Holt, S. E., Aisner, D. L., Shay, J. W. & Wright, W. E. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA 94, 10687-10692 (1997).
42. Vogan, J. M. & Collins, K. Dynamics of human telomerase holoenzyme assembly and subunit exchange across the cell cycle. J. Biol. Chem. 290, 21320-21335 (2015).
43. Stern, J. L., Zyner, K. G., Pickett, H. A., Cohen, S. B. & Bryan, T. M. Telomerase recruitment requires both TCAB1 and Cajal bodies independently. Mol. Cell. Biol. 32, 2384-2395 (2012).
44. Zhong, F. et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 25, 11-16 (2011).
45. Jády, B. E., Bertrand, E. & Kiss, T. Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body-specific localization signal. J. Cell Biol. 164, 647-652 (2004).
46. Tomlinson, R. L., Li, J., Culp, B. R., Terns, R. M. & Terns, M. P. A Cajal body-independent pathway for telomerase trafficking in mice. Exp. Cell Res. 316, 2797-2809 (2010).
47. Cusanelli, E., Romero, C. A. & Chartrand, P. Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol. Cell 51, 780-791 (2013).
48. Chen, Y. et al. Human cells lacking coilin and Cajal bodies are proficient in telomerase assembly, trafficking and telomere maintenance. Nucleic Acids Res. 43, 385-395 (2015).
49. Cristofari, G. et al. Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol. Cell 27, 882-889 (2007).
50. Smogorzewska, A. & de Lange, T. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208 (2004).
51. van Steensel, B. & de Lange, T. Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743 (1997).
52. Smogorzewska, A. et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20, 1659-1668 (2000).
53. Ancelin, K. et al. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol. Cell. Biol. 22, 3474-3487 (2002).
54. Loayza, D. & De Lange, T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018 (2003).
55. Schoeftner, S. & Blasco, M. A. Chromatin regulation and non-coding RNAs at mammalian telomeres. Semin. Cell Dev. Biol. 21, 186-193 (2010).
56. Canudas, S. et al. A role for heterochromatin protein 1 at human telomeres. Genes Dev. 25, 1807-1819 (2011).
57. Nandakumar, J. et al. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature 492, 285-289 (2012).
58. Sexton, A. N., Youmans, D. T. & Collins, K. Specificity requirements for human telomere protein interaction with telomerase holoenzyme. J. Biol. Chem. 287, 34455-34464 (2012).
59. Zhong, F. L. et al. TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell 150, 481-494 (2012).
60. Sexton, A. N. et al. Genetic and molecular identification of three human TPP1 functions in telomerase action: recruitment, activation, and homeostasis set point regulation. Genes Dev. 28, 1885-1899 (2014).
61. Schmidt, J. C., Dalby, A. B. & Cech, T. R. Identification of human TERT elements necessary for telomerase recruitment to telomeres. eLife 3, e03563 (2014).
62. Nakashima, M., Nandakumar, J., Sullivan, K. D., Espinosa, J. M. & Cech, T. R. Inhibition of telomerase recruitment and cancer cell death. J. Biol. Chem. 288, 33171-33180 (2013).
63. Hwang, H., Buncher, N., Opresko, P. L. & Myong, S. POT1-TPP1 regulates telomeric overhang structural dynamics. Structure 20, 1872-1880 (2012).
64. Lei, M., Zaug, A. J., Podell, E. R. & Cech, T. R. Switching human telomerase on and off with hPOT1 protein in vitro. J. Biol. Chem. 280, 20449-20456 (2005).
65. Zaug, A. J., Podell, E. R. & Cech, T. R. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc. Natl. Acad. Sci. USA 102, 10864-10869 (2005).
66. Kelleher, C., Kurth, I. & Lingner, J. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol. Cell. Biol. 25, 808-818 (2005).
67. Churikov, D. & Price, C. M. Pot1 and cell cycle progression cooperate in telomere length regulation. Nat. Struct. Mol. Biol. 15, 79-84 (2008).
68. Ye, J. Z. et al. POT1-interacting protein PIP1: A telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18, 1649-1654 (2004).
69. Rai, R. et al. The E3 ubiquitin ligase Rnf8 stabilizes Tpp1 to promote telomere end protection. Nat. Struct. Mol. Biol. 18, 1400-1407 (2011).
70. Zemp, I. & Lingner, J. The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7. J. Biol. Chem. 289, 28595-28606 (2014).
71. Savage, S. A. et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 82, 501-509 (2008).
72. Walne, A. J., Vulliamy, T., Beswick, R., Kirwan, M. & Dokal, I. TINF2 mutations result in very short telomeres: Analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 112, 3594-3600 (2008).
73. Frescas, D. & de Lange, T. A. TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice. Genes Dev. 28, 153-166 (2014).
74. Yang, D., He, Q., Kim, H., Ma, W. & Songyang, Z. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase. J. Biol. Chem. 286, 23022-23030 (2011).
75. Price, C. M. et al. Evolution of CST function in telomere maintenance. Cell Cycle 9, 3157-3165 (2010).
76. Casteel, D. E. et al. A DNA polymerase-primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J. Biol. Chem. 284, 5807-5818 (2009).
77. Lue, N. F., Chan, J., Wright, W. E. & Hurwitz, J. The CDC13-STN1-TEN1 complex stimulates Pol activity by promoting RNA priming and primase-to-polymerase switch. Nat. Commun. 5, 5762 (2014).
78. Chen, L. Y., Redon, S. & Lingner, J. The human CST complex is a terminator of telomerase activity. Nature 488, 540-544 (2012).
79. Wu, P., Takai, H. & de Lange, T. Telomeric 3 overhangs derive from resection by Exo1 and Apollo and fill-in by POT1b-associated CST. Cell 150, 39-52 (2012).
80. Lenain, C. et al. The Apollo 5 exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr. Biol. 16, 1303-1310 (2006).
81. van Overbeek, M. & de Lange, T. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr. Biol. 16, 1295-1302 (2006).
82. Touzot, F. et al. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome. Proc. Natl. Acad. Sci. USA 107, 10097-10102 (2010).
83. Armstrong, C. A., Pearson, S. R., Amelina, H., Moiseeva, V. & Tomita, K. Telomerase activation after recruitment in fission yeast. Curr. Biol. 24, 2006-2011 (2014).